By Business/Source
Currency:EUR
2025/FY
Stock NameRevenueRatio
Discovery & Preclinical Development (D&PD)529.28M67.14%
Just – Evotec Biologics259.59M32.93%
Intersegment Eliminations-496K-0.06%
By Country/Region
Currency:EUR
2025/FY
Stock NameRevenueRatio
USA431.51M54.73%
Switzerland161.61M20.50%
Rest Of The World77.09M9.78%
United Kingdom (UK)61.72M7.83%
Germany25.29M3.21%
France19.86M2.52%
Revenue from contributions11.29M1.43%
View all